文献速递神经康复言语与吞咽障碍儿童康复

雾化格隆溴铵治疗脑损伤患者后流涎:两例不同脑病变报告

The Effect of Nebulized Glycopyrrolate on Posterior Drooling in Patients with Brain Injury: Two Cases of Different Brain Lesions.
PubMed 文献 · Am J Phys Med Rehabil · 2017-01-01

本文报告两例后流涎患者(82岁男性双侧偏瘫卒中患者与1岁女性脑瘫婴儿伴双侧痉挛性偏瘫),采用雾化格隆溴铵治疗,并用放射性核素唾液显像识别唾液误吸及评估疗效。作者认为,鉴于其无创且中枢不良反应较少,雾化格隆溴铵可考虑用于认知或吞咽功能受损的严重脑损伤患者后流涎管理。

要点

  • 后流涎可致不明原因肺病与反复肺炎,是康复单元重要问题。
  • 雾化格隆溴铵无创且不易透过血脑屏障,中枢不良反应相对较少。
  • 两例不同脑病变患者用放射性核素唾液显像评估后流涎与疗效。

核心结论

  • 雾化格隆溴铵可考虑作为认知或吞咽功能受损的严重脑损伤患者后流涎管理方法之一。

研究设计与样本

  • 两例病例报告:一例82岁男性双侧偏瘫卒中患者,一例1岁女性脑瘫婴儿伴双侧痉挛性偏瘫。
  • 采用放射性核素唾液显像识别唾液误吸并评估雾化格隆溴铵的效果。

主要发现

  • 两例后流涎患者接受雾化格隆溴铵治疗,并通过放射性核素唾液显像评估唾液误吸与疗效。
  • 作者指出此前仅有1例运动神经元病患者雾化格隆溴铵治疗流涎的病例报告,尚无后流涎疗效报告。

临床怎么用

  • 对认知或吞咽功能受损的严重脑损伤后流涎患者,可考虑雾化格隆溴铵作为管理选择之一。
  • 可用放射性核素唾液显像识别唾液误吸并评估治疗效果。

局限性

  • 证据仅来自两例病例报告,样本量小,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Posterior drooling, which can lead to substantial respiratory morbidity, including unexplained lung diseases and recurrent pneumonia, is an important issue in the rehabilitation unit. There are various treatment options for posterior drooling, including pharmacologic therapy, oral motor or behavioral therapy, biofeedback, local glandular injection of botulinum toxin, irradiation, and surgery. Among them, nebulized glycopyrrolate has the following advantages: It is noninvasive and is relatively free of central adverse effects because it does not cross the blood-brain barrier unlike other anticholinergics. Although there has been one case report regarding the effectiveness of nebulized glycopyrrolate for drooling in a motor neuron patient, there have not been any reports on its effectiveness for posterior drooling. Herein, we report two cases (an 82-year-old male bilateral hemiplegic stroke patient and a 1-year-old female cerebral palsy infant with bilaterally spastic hemiplegia of posterior drooling treated with nebulized glycopyrrolate) and identify salivary aspiration and the effect of nebulized glycopyrrolate using radionuclide salivagram. Considering its advantages and effectiveness, nebulized glycopyrrolate should be considered as one of the reliable methods to manage posterior drooling in patients with impaired cognition or swallowing difficulties, such as severe brain injury.

来源:Am J Phys Med Rehabil,查看原文。版权归原作者所有。

引用

  1. Lee ZI, Yu KJ, Lee DH, et al. The Effect of Nebulized Glycopyrrolate on Posterior Drooling in Patients with Brain Injury: Two Cases of Different Brain Lesions. Am J Phys Med Rehabil. 2017. PMID: 28081026. doi:10.1097/PHM.0000000000000669

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。